Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer
Press Release Dren Bio, Inc. (“Dren Bio” or the “Company”) a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of its leadership team with the appointment of Amit…
Amit Mehta Jeff Macfarland Nenad Tomasevic Early Stage Portfolio Committee Early Development Leadership Team Company Contact
Source: venturebeat.com